Business Description
Vaidya Sane Ayurved Laboratories Ltd
ISIN : INE0JR301013
Compare
Compare
Traded in other countries / regions
MADHAVBAUG.India IPO Date
2022-02-23Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.54 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.27 | |||||
| Interest Coverage | 8.76 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.23 | |||||
| Beneish M-Score | -1.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.5 | |||||
| 3-Year EBITDA Growth Rate | 17.5 | |||||
| 3-Year EPS without NRI Growth Rate | -1.2 | |||||
| 3-Year Book Growth Rate | 78.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.84 | |||||
| 9-Day RSI | 50.18 | |||||
| 14-Day RSI | 51.42 | |||||
| 6-1 Month Momentum % | -19.44 | |||||
| 12-1 Month Momentum % | -44.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | |||||
| Quick Ratio | 2.11 | |||||
| Cash Ratio | 1.39 | |||||
| Days Inventory | 51.72 | |||||
| Days Sales Outstanding | 24.32 | |||||
| Days Payable | 101.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -10.37 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.12 | |||||
| Operating Margin % | 2.19 | |||||
| Net Margin % | 1.99 | |||||
| FCF Margin % | -15.66 | |||||
| ROE % | 3.94 | |||||
| ROA % | 3.05 | |||||
| ROIC % | 4.04 | |||||
| ROC (Joel Greenblatt) % | 13.62 | |||||
| ROCE % | 6 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 93.76 | |||||
| PE Ratio without NRI | 110.75 | |||||
| PEG Ratio | 4.07 | |||||
| PS Ratio | 1.86 | |||||
| PB Ratio | 2.78 | |||||
| Price-to-Tangible-Book | 3.18 | |||||
| EV-to-EBIT | 44.04 | |||||
| EV-to-EBITDA | 21.93 | |||||
| EV-to-Revenue | 1.38 | |||||
| EV-to-FCF | -8.87 | |||||
| Price-to-Peter-Lynch-Fair-Value | 4.52 | |||||
| Price-to-Graham-Number | 3.95 | |||||
| Price-to-Net-Current-Asset-Value | 8.51 | |||||
| Price-to-Net-Cash | 38.04 | |||||
| Earnings Yield (Greenblatt) % | 2.29 | |||||
| FCF Yield % | -10.06 | |||||
| Forward Rate of Return (Yacktman) % | 13.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaidya Sane Ayurved Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 993.313 | ||
| EPS (TTM) (₹) | 1.57 | ||
| Beta | 0 | ||
| Volatility % | 41.68 | ||
| 14-Day RSI | 51.42 | ||
| 14-Day ATR (₹) | 7.173882 | ||
| 20-Day SMA (₹) | 147.025 | ||
| 12-1 Month Momentum % | -44.88 | ||
| 52-Week Range (₹) | 107 - 251 | ||
| Shares Outstanding (Mil) | 10.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaidya Sane Ayurved Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaidya Sane Ayurved Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaidya Sane Ayurved Laboratories Ltd Frequently Asked Questions
What is Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG)'s stock price today?
The current price of NSE:MADHAVBAUG is ₹147.20. The 52 week high of NSE:MADHAVBAUG is ₹251.00 and 52 week low is ₹107.00.
When is next earnings date of Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG)?
The next earnings date of Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG) is .
Does Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG) pay dividends? If so, how much?
Vaidya Sane Ayurved Laboratories Ltd(NSE:MADHAVBAUG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers